These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35699966)
41. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study. Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537 [TBL] [Abstract][Full Text] [Related]
42. Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis. Young J; Sawyer J; Jenkins M; O'Brien M; Luchtman-Jones L; Breese EH Pediatr Blood Cancer; 2019 Jun; 66(6):e27719. PubMed ID: 30900794 [TBL] [Abstract][Full Text] [Related]
43. Venous Thrombosis in Children with Acute Lymphoblastic Leukemia Treated on DCOG ALL-9 and ALL-10 Protocols: The Effect of Fresh Frozen Plasma. Klaassen ILM; Zuurbier CCM; Hutten BA; van den Bos C; Schouten AYN; Stokhuijzen E; van Ommen CH TH Open; 2019 Apr; 3(2):e109-e116. PubMed ID: 31249990 [No Abstract] [Full Text] [Related]
44. Symptomatic severe hypertriglyceridaemia with asparaginase therapy in acute lymphoblastic leukaemia (ALL) and lymphoblastic lymphoma: is rechallenging safe? Lashkari HP; Lancaster D; Atra A; Champion MP; Taj MM Int J Hematol; 2011 Dec; 94(6):571-5. PubMed ID: 22057510 [TBL] [Abstract][Full Text] [Related]
46. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe. Qureshi A; Mitchell C; Richards S; Vora A; Goulden N Br J Haematol; 2010 May; 149(3):410-3. PubMed ID: 20201945 [TBL] [Abstract][Full Text] [Related]
47. Management of adverse effects associated with pegylated Escherichia coli asparaginase on coagulation in the treatment of patients with NK/T-cell lymphoma. Yang J; Guo X; Guo S; Yan H; Chai L; Guo Y; Li Z; Hao Z; Su L Medicine (Baltimore); 2022 Mar; 101(10):e25578. PubMed ID: 35451376 [TBL] [Abstract][Full Text] [Related]
48. Successful treatment with apixaban of sinus venous thrombosis due to pegylated asparaginase in a young adult with T cell acute lymphoblastic leukemia: case report and review of management. Talamo L; Douvas M; Macik BG; Ornan D Ann Hematol; 2017 Apr; 96(4):691-693. PubMed ID: 28132079 [No Abstract] [Full Text] [Related]
53. Correction of hemostatic imbalances induced by L-asparaginase therapy in children with acute lymphoblastic leukemia. Zaunschirm A; Muntean W Pediatr Hematol Oncol; 1986; 3(1):19-25. PubMed ID: 3153215 [TBL] [Abstract][Full Text] [Related]
54. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia. Truelove E; Fielding AK; Hunt BJ Leukemia; 2013 Mar; 27(3):553-9. PubMed ID: 23099335 [TBL] [Abstract][Full Text] [Related]
55. The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance. Horvat TZ; Pecoraro JJ; Daley RJ; Buie LW; King AC; Rampal RK; Tallman MS; Park JH; Douer D Leuk Res; 2016 Nov; 50():17-20. PubMed ID: 27631159 [TBL] [Abstract][Full Text] [Related]
56. Outcome of pediatric patients with acute lymphoblastic leukemia/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: A report from the Children's Oncology Group. Rau RE; Dreyer Z; Choi MR; Liang W; Skowronski R; Allamneni KP; Devidas M; Raetz EA; Adamson PC; Blaney SM; Loh ML; Hunger SP Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29090524 [TBL] [Abstract][Full Text] [Related]
57. A regimen for antithrombin III substitution in patients with acute lymphoblastic leukemia under treatment with L-asparaginase. Mattioli Belmonte M; Gugliotta L; Delvos U; Catani L; Vianelli N; Cascione ML; Belardinelli AR; Mottola L; Tura S Haematologica; 1991; 76(3):209-14. PubMed ID: 1743591 [TBL] [Abstract][Full Text] [Related]
58. Thromboembolism prophylaxis during L-asparaginase therapy in acute lymphoblastic leukemia - time to reconsider current approaches? Fulcher J; Carrier M Thromb Res; 2020 Apr; 188():100-102. PubMed ID: 32120278 [TBL] [Abstract][Full Text] [Related]
59. Bleeding and thrombosis in children with acute lymphoblastic leukaemia, treated according to the ALL-BFM-90 protocol. Sutor AH; Mall V; Thomas KB Klin Padiatr; 1999; 211(4):201-4. PubMed ID: 10472550 [TBL] [Abstract][Full Text] [Related]